MARKET

DNABW

DNABW

Ginkgo Bioworks Holdings Inc
OTCPK
0.0015
NaN%
Closed 09:30 05/20 EDT
OPEN
--
PREV CLOSE
0.0015
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.350
52 WEEK LOW
0.0014
MARKET CAP
--
P/E (TTM)
-0.0003
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DNABW last week (0511-0515)?
Weekly Report · 2d ago
Weekly Report: what happened at DNABW last week (0504-0508)?
Weekly Report · 05/11 10:42
Ginkgo outlines $125M-$150M 2026 cash burn guidance while expanding Nebula to 103 racks
Seeking Alpha · 05/08 03:33
Weekly Report: what happened at DNABW last week (0427-0501)?
Weekly Report · 05/04 10:38
Weekly Report: what happened at DNABW last week (0420-0424)?
Weekly Report · 04/27 10:42
Weekly Report: what happened at DNABW last week (0413-0417)?
Weekly Report · 04/20 10:37
Weekly Report: what happened at DNABW last week (0406-0410)?
Weekly Report · 04/13 10:41
Weekly Report: what happened at DNABW last week (0330-0403)?
Weekly Report · 04/06 10:42
More
About DNABW
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It also focuses on the design of next-generation cell therapies for autoimmune diseases. It uses its platform to develop and screen libraries of novel NK-specific and T-cell specific chimeric antigen receptor and switch receptor designs, which enable control and performance of immune cell-based therapies.

Webull offers Ginkgo Bioworks Holdings Inc stock information, including OTCPK: DNABW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNABW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNABW stock methods without spending real money on the virtual paper trading platform.